Thomas James Robbins is a Ensley, Alabama based nurse practitioner. Active license number of Thomas James Robbins is 1-135511 in Alabama. His current practice location is 1925 Avenue E, Ensley. Patients can reach him at 205-788-5164. Thomas James Robbins is CRNP and his NPI number (Unique professional ID assigned by NPPES) is 1326654609. Thomas James Robbins has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Thomas James Robbins speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1326654609
NPI Enumeration Date:
22 Sep, 2020
NPI Last Update On:
02 Nov, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Thomas James Robbins are as mentioned below.
License Number
Specialization
State
Status
1-135511
Alabama
Primary
1-135511
Registered Nurse
Alabama
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Thomas James Robbins 405 Belcher St, Centreville, Alabama
Zip:
35042-2946
Phone Number:
205-926-2992
Patients can reach Thomas James Robbins at 1925 Avenue E, Ensley, Alabama or can call to book an appointment on 205-788-5164.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.